Johnson & Johnson (Biosense Webster) announced the launch of its new disposable magnetic positioning paddle-type mapping catheter---OPTRELL™Approved by NMPA for marketing, this is currently the most advanced product approved by NMPA.PaddleType Mapping Catheter.
Arrhythmia is due toSinoatrial NodeExcitation occurs abnormally or originates outside the sinoatrial node, with slow conduction, blockage, or conduction through abnormal pathways, meaning that disorders in the origin and/or conduction of cardiac activity lead to abnormalities in heart rate and/or rhythm.Atrial fibrillation is the most common type of arrhythmia, affecting nearly 40 million people worldwide, including nearly 20 million atrial fibrillation patients in China.Atrial fibrillation is a progressive disease. If not treated in time, it may continue to worsen over time and can even lead to serious complications such as heart disease or stroke.Electrophysiological ablation is the most effective method for treating atrial fibrillation. Currently, the methods of electrophysiological ablation include radiofrequency ablation, cryoablation, PFA, and more. Regardless of the ablation method used, it is necessary to accurately locate before ablation.Arrhythmia location, canDevelop more effective ablation strategies.In clinical practice, advanced 3D mapping technology is often required to accurately and quickly identify arrhythmias. In this field, Johnson & Johnson has always been an industry leader, with advanced...CARTO 3 Three-Dimensional Mapping System, or mapping catheters with various shapes (to adapt to the physiological structure of the heart).In terms of mapping catheters, Johnson & Johnson has always been in a leading position in the industry, and its upcoming paddle-type catheterOPTRELL™Also showed a very large lead over the Advisor HD Grid, which is also paddle-type.OPTRELL™Compared with HD Grid, it shows great advantages in the number of electrodes, andOPTRELL™It also features smaller electrode size and smaller electrode spacing, along with an exclusiveTUREref™Technology will undoubtedly bring a better surgical experience in terms of mapping efficiency and potential clarity. In the future,OPTRELL™It will also be paired with the updated C3 system to bring a completely new mapping experience. The following isOPTRELL™Comparison Chart with Advisor HD Grid.CARTO 3+ Johnson & Johnson's technical沉淀 in catheters (ablation catheters and mapping catheters) is the foundation for its dominance in the electrophysiology field.
OPTRELL
OPTRELL™It is an 8.5Fr mapping catheter with bidirectional deflection.Function.OPTRELL™The distal end is connected to six small parallel catheters (catheter diameter 2Fr), with the six catheters paired together to form three loops.
OPTRELL™Available in four specifications, each small catheter is equipped with 6 or 8 platinum electrodes, spaced 2.4mm apart (both longitudinally and transversely), with each electrode measuring only 460μm in length.
OPTRELL™The "paddle" has two bending methods, D-F and F-J.
OPTRELL™Like the OCTARAY launched by Johnson & Johnson last year, both adoptTUREref™Technology. ExclusiveTUREref™Noise reduction technology, mapping with higher precision and detail, improving signal quality. Thus,OPTRELL™With ultra-high definition.
OPTRELL™Can be used in conjunction with CARTO 3, providing intelligent activation views and high-resolution directional mapping of the mapping area through real-time vector arrows.
OPTRELL
Biosense Webster Biosense Webster, Inc., a professional medical device company under Johnson & Johnson, is dedicated to the research and development of electrophysiological interventional diagnosis and treatment products, providing comprehensive solutions for arrhythmia diseases to physicians and patients. Biosense Webster stands as a world leader in 3D mapping systems and software with its excellent and innovative technology.It is also the inventor of the world's first curved catheter.
